(Q39325949)

11 September 2017

title

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence (English)

1 reference

11 September 2017

main subject

hepatocellular carcinoma

1 reference

Tai-Wei Sun

1

1 reference

11 September 2017

Qiang Gao

2

1 reference

11 September 2017

Shuang-Jian Qiu

3

1 reference

11 September 2017

Jian Zhou

4

1 reference

11 September 2017

Xiao-Ying Wang

5

1 reference

11 September 2017

Yong Yi

6

1 reference

11 September 2017

Jie-Yi Shi

7

1 reference

11 September 2017

Yong-Feng Xu

8

1 reference

11 September 2017

Ying-Hong Shi

9

1 reference

11 September 2017

Kang Song

10

1 reference

11 September 2017

Yong-Sheng Xiao

11

1 reference

11 September 2017

Jia Fan

12

1 reference

11 September 2017

publication date

22 May 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

61

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

2171-2182

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1278-5

11 September 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

The contrasting role of B7-H3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Clinical importance of B7-H3 expression in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Diagnosis value of serum B7-H3 expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1278-5

10.1007/S00262-012-1278-5

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference